About this trial
The rationale of the current research is to address the limitation of existing knowledge as it is not clear which of the two drugs (Dexamethasone or Methylprednisolone) is more effective in reduction of postoperative sequelae in patient with mandibular parasymphysis fracture. This study fills the gap by providing sound evidence on the preferred steroid option to help clinicians have more data to make decisions and improve patients' health. The result of this research will then be added to the evidence-based protocols for the treatment of parasymphysis fractures.
Eligibility criteria
Qualifiers
Patients aged 18 to 40.
Both Gender.
Fracture less than a week old.
Isolated mandibular parasymphysis fractures.
Disqualifiers
1. Immunocompromised patients (due to increased risk of infection and complications).
Trial design
Treatments tested in this trial
- Dexamethasone
- Methylprednisolone (Corticosteroid)
Treatment groups
Sponsors and collaborators
Nishtar Medical University
Lead sponsor
University of Health Sciences Lahore
Sponsor institution